Tecovirimat

SI-5230

Tecovirimat, >98% (HPLC)

CAS No. : [869572-92-9]

MDL No. : MFCD11973644

IUPAC Name : 4-Trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop(f)isoindol-2(1H)-yl)-benzamide

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Tecovirimat is a core protein cysteine protease inhibitor potentially for treatment of smallpox infection. Tecovirimat is a novel antiviral that inhibits the egress of orthopoxviruses by targeting viral p37 protein orthologs. Tecovirimat has shown efficacy in all small animal and nonhuman primate prophylaxis and therapeutic efficacy models of poxvirus-induced disease tested to date.

References : Lindholm D. A. et al.: Clin Infect Dis., 69(12), 2205-2207, 2019; Chan-Tack K. M. et al.: Lancet Infect Dis., 19(6), e221-e224, 2019; Laudisoit A. N. Engl J. Med., 379(21), 2084-2085, 2018; Russo A. T. et al.: J. Infect Dis., 218(9), 1490-1499, 2018; Grosenbach D. W. et al.: N. Engl J. Med., 379(1), 44-53, 2018; Berhanu A. et al.: Antimicrob Agents Chemother., 59(7), 4296-300, 2015.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.